Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04903119
Title Nilotinib Plus Dabrafenib/Trametinib in Metastatic Melanoma
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Peng Wang, MD PhD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Markey Cancer Center RECRUITING Lexington Kentucky 40536 United States Details
St. Luke's University Health Network RECRUITING Easton Pennsylvania 18045 United States Details
Vanderbilt-Ingram Cancer Center RECRUITING Nashville Tennessee 37232 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field